Does Noritate (metronidazole) cause side effects?
Common side effects of Noritate include
- skin dryness,
- scaling, and
- itching at the site of application.
Serious side effects of Noritate include
- severe skin stinging or burning.
Drug interactions with Noritate cream are unlikely because only small amounts of Noritate are absorbed into the body when Noritate cream is applied to the skin.
- Oral metronidazole interacts with warfarin, increasing the blood-thinning effects of warfarin. It is not known whether the small amounts of Noritate absorbed via the skin can cause the same interaction.
There are no adequate studies of Noritate cream in pregnant women.
When metronidazole is administered orally it is secreted into breast milk in concentrations similar to the concentration in the mother’s body. Therefore, small amounts of metronidazole that are absorbed into the body when Noritate cream is used may be secreted into breast milk. Consult your doctor before breastfeeding.
Noritate (metronidazole) side effects list for healthcare professionals
Safety data from 302 patients who used Noritate (metronidazole) (n=200) or vehicle control (n=102) once daily in clinical trials and experienced an adverse event considered to be treatment-related include:
- application site reaction (Noritate (metronidazole) 1, vehicle 1),
- condition aggravated (Noritate (metronidazole) 1, vehicle 0),
- paresthesia (Noritate (metronidazole) 0, vehicle 1),
- acne (Noritate (metronidazole) 1, vehicle 0),
- dry skin (Noritate (metronidazole) 0, vehicle 2).
The majority of adverse reactions were mild to moderate in severity.
What drugs interact with Noritate (metronidazole)?
Oral metronidazole has been reported to potentiate the anticoagulant effect of coumarin and warfarin resulting in a prolongation of prothrombin time.
Drug interactions should be kept in mind when Noritate (metronidazole) is prescribed for patients who are receiving anticoagulant treatment, although they are less likely to occur with topical metronidazole administration because of low absorption.
Carcinogenesis, Mutagenesis and Impairment of Fertility
- Metronidazole has shown evidence of carcinogenic activity in a number of studies involving chronic, oral administration in mice and rats but not in studies involving hamsters.
- In several long term studies in mice, oral doses of approximately 225 mg/m2/day or greater (approximately 37 times the human topical dose on a mg/m2 basis) were associated with an increase in pulmonary tumors and lymphomas.
- Several long term oral studies in the rat have shown statistically significant increases in mammary and hepatic tumors at doses >885 mg/m2/day (144 times the topical human dose).
- Metronidazole has shown evidence of mutagenic activity in several in vitro bacterial assay systems. In addition, a dose-related increase in the frequency of micronuclei was observed in mice after intraperitoneal injections.
- An increase in chromosomal aberrations in peripheral blood lymphocytes was reported in patients with Crohn's disease who were treated with 200 to 1200 mg/day of metronidazole for 1 to 24 months.
- However, in another study, no increase in chromosomal aberrations in circulating lymphocytes was observed in patients with Crohn's disease treated with the drug for 8 months.
- In one published study, using albino hairless mice, intraperitoneal administration of metronidazole at a dose of 45 mg/m2/day (approximately 7 times the human topical dose on a mg/m2 basis) was associated with an increase in ultraviolet radiation-induced skin carcinogenesis.
- Neither dermal carcinogenicity nor photocarcinogenicity studies have been performed with Noritate or any marketed metronidazole formulations.
- Teratogenic Effects: Pregnancy Category B. There are no adequate and well controlled studies with the use of Noritate (metronidazole) in pregnant women.
- Metronidazole crosses the placental barrier and enters the fetal circulation rapidly.
- No fetotoxicity was observed after oral administration of metronidazole to rats or mice at 200 and 20 times, respectively, the expected clinical dose.
- However, oral metronidazole has shown carcinogenic activity in rodents. Because animal reproduction studies are not always predictive of human response, Noritate (metronidazole) should be used during pregnancy only if clearly needed.
- Nursing Mothers: After oral administration, metronidazole is secreted in breast milk in concentrations similar to those found in the plasma.
- Even though blood levels taken after topical metronidazole application are significantly lower than those achieved after oral metronidazole, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother and the risk to the infant.
- Safety and effectiveness in pediatric patients have not been established.
Noritate (metronidazole cream) is a topical preparation (applied to the skin) of the antibiotic metronidazole used to reduce the swelling and redness caused by acne rosacea. Common side effects of Noritate include irritation, skin dryness, scaling, and itching at the site of application. Serious side effects of Noritate include severe skin stinging or burning. There are no adequate studies of Noritate cream in pregnant women. Small amounts of metronidazole that are absorbed into the body when Noritate cream is used may be secreted into breast milk.
Multimedia: Slideshows, Images & Quizzes
Rosacea, Acne, Shingles, Covid-19 Rashes: Common Adult Skin Diseases
Learn to spot and treat skin conditions commonly found in adults such as acne, Covid-19 rashes, eczema, shingles, psoriasis,...
Skin Diseases: 15 Uncommon Skin Conditions
Genetic illnesses, health conditions, or infections cause your skin to react in unusual ways. Learn about these conditions and...
Skin Health: How to Get Clear Skin
Acne, pimples, zits and blemishes often appear on the face, back, chest, neck, and shoulders where skin has the most amount of...
Skin Health: The Creatures That Live on Your Body
You may try not to think about it, but the truth is there are tiny creatures living all over your body. Learn which ones are OK...
Think acne and rosacea are the same? Think again. Take the Rosacea Quiz to learn all about this inflammatory skin condition.
Skin Problems and Treatments: Surprising Reasons You're Itchy
Find out some unexpected causes of your itchiness, such as thyroid problems, cancer treatments, pregnancy, diabetes, and more.
Skin Conditions Quiz: Common Skin Diseases
Could you identify a scabies infestation? Take the Skin Diseases Pictures Quiz and learn to identify common conditions that...
Skin Quiz: Acne, Dry Skin, Dandruff & More
What's that all over you? Skin, of course! Test your knowledge of your most amazing organ with the Skin Quiz!
Picture of Rosacea 2
Rosacea is an inflammatory condition of the midface characterized by the presence of erythema, papules, pustules,...
Picture of Skin
The skin is the largest organ of the body, with a total area of about 20 square feet. See a picture of the Skin and learn more...
Picture of Rosacea 1
Rosacea (say "roh-ZAY-sha") is a skin disease that causes redness and pimples on your nose, cheeks, chin, and forehead. See a...
Related Disease Conditions
Rosacea is a skin disease that causes redness of the forehead, chin, and lower half of the nose. In addition to inflammation of the facial skin, symptoms include dilation of the blood vessels and pimples (acne rosacea) in the middle third of the face. Oral and topical antibiotics are treatments for rosacea. If left untreated, rhinophyma (a disfiguring nose condition) may result.
Triggers That May Cause Your Rosacea Flare-ups
Anything that causes your rosacea to flare up is called a trigger. Sun exposure and emotional stress are the most common triggers for rosacea flare-ups in most patients.
Treatment & Diagnosis
Medications & Supplements
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Professional side effects and drug interactions sections courtesy of the U.S. Food and Drug Administration.